Corcept Therapeutics Inc’s recent filing unveils that its insider Maduck Sean unloaded Company’s shares for reported $0.32 million on Jul 17 ’25. In the deal valued at $73.48 per share,4,315 shares were sold. As a result of this transaction, Maduck Sean now holds 17,705 shares worth roughly $1.24 million.
Then, Maduck Sean sold 473 shares, generating $34,737 in total proceeds. Upon selling the shares at $73.44, the insider now owns 17,705 shares.
Before that, BELANOFF JOSEPH K sold 615 shares. Corcept Therapeutics Inc shares valued at $45,318 were divested by the Chief Executive Officer at a price of $73.69 per share. As a result of the transaction, BELANOFF JOSEPH K now holds 2,901,370 shares, worth roughly $203.44 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Monday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock fall -1.04% to $70.12. Over the last five days, the stock has lost -3.64%. Corcept Therapeutics Inc shares have risen nearly 110.95% since the year began. Nevertheless, the stocks have risen 39.15% over the past one year.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-06-13, growing by 0.17 million shares to a total of 12.65 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 12.48 million shares. There was a rise of 1.35%, which implies that there is a positive sentiment for the stock.
